Akari Therapeutics, Plc
AKTX
$3.06
-$2.09-40.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 109.46% | -8.37% | 5.00% | -0.65% | 15.72% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -46.99% | -21.92% | -28.71% | 581.52% | -76.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -34.51% | -20.98% | 2.14% | -46.36% | 183.70% |
| Total Current Assets | 85.40% | -10.75% | -1.43% | 13.45% | 7.97% |
|
|
|||||
| Total Current Assets | 85.40% | -10.75% | -1.43% | 13.45% | 7.97% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Other Intangibles | 0.00% | -13.22% | 0.00% | 0.00% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 5.54% | -10.87% | -0.09% | 0.79% | 1,749.38% |
|
|
|||||
| Total Accounts Payable | -19.13% | -6.57% | -11.17% | 5.32% | 159.45% |
| Total Accrued Expenses | 44.30% | -34.24% | -29.36% | 11.38% | 20.42% |
| Short-term Debt | -64.38% | 36.85% | -16.20% | -43.37% | 226.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -50.71% | -35.09% | -39.36% | 126.04% | 6.24% |
| Total Other Current Liabilities | -50.71% | -35.09% | -39.36% | 126.04% | 6.24% |
| Total Current Liabilities | -20.66% | -9.16% | -18.03% | 5.01% | 111.18% |
|
|
|||||
| Total Current Liabilities | -20.66% | -9.16% | -18.03% | 5.01% | 111.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -64.38% | 36.85% | -16.20% | -43.37% | 226.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.73% | -14.04% | -1.66% | -1.39% | -- |
| Total Liabilities | -13.77% | -10.34% | -13.37% | 3.11% | 200.52% |
|
|
|||||
| Common Stock & APIC | 1.49% | 1.55% | 2.75% | 1.49% | 17.52% |
| Retained Earnings | -2.04% | -2.53% | -0.76% | -1.50% | -1.55% |
| Treasury Stock & Other | 14.71% | -0.07% | -0.65% | -0.07% | 0.37% |
| Total Common Equity | 24.86% | -11.40% | 17.75% | -2.17% | 432.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.86% | -11.40% | 17.75% | -2.17% | 432.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.86% | -11.40% | 17.75% | -2.17% | 432.07% |
|
|
|||||